These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33528040)

  • 1. Translating antenatal magnesium sulphate neuroprotection for infants born <28 weeks' gestation into practice: A geographical cohort study.
    Doyle LW; Spittle AJ; Olsen JE; Kwong A; Boland RA; Lee KJ; Anderson PJ; Cheong JLY;
    Aust N Z J Obstet Gynaecol; 2021 Aug; 61(4):513-518. PubMed ID: 33528040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the neuroprotective benefits for babies of antenatal magnesium sulphate: An individual participant data meta-analysis.
    Crowther CA; Middleton PF; Voysey M; Askie L; Duley L; Pryde PG; Marret S; Doyle LW;
    PLoS Med; 2017 Oct; 14(10):e1002398. PubMed ID: 28976987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnesium sulphate and perinatal mortality and morbidity in very-low-birthweight infants born between 24 and 32 weeks of gestation in Japan.
    Ohhashi M; Yoshitomi T; Sumiyoshi K; Kawagoe Y; Satoh S; Sameshima H; Ikenoue T
    Eur J Obstet Gynecol Reprod Biol; 2016 Jun; 201():140-5. PubMed ID: 27131232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No. 376-Magnesium Sulphate for Fetal Neuroprotection.
    Magee LA; De Silva DA; Sawchuck D; Synnes A; von Dadelszen P
    J Obstet Gynaecol Can; 2019 Apr; 41(4):505-522. PubMed ID: 30879485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnesium sulphate at 30 to 34 weeks' gestational age: neuroprotection trial (MAGENTA)--study protocol.
    Crowther CA; Middleton PF; Wilkinson D; Ashwood P; Haslam R;
    BMC Pregnancy Childbirth; 2013 Apr; 13():91. PubMed ID: 23570677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Working to improve survival and health for babies born very preterm: the WISH project protocol.
    Crowther CA; Middleton PF; Bain E; Ashwood P; Bubner T; Flenady V; Morris J; McIntyre S;
    BMC Pregnancy Childbirth; 2013 Dec; 13():239. PubMed ID: 24354790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus.
    Doyle LW; Crowther CA; Middleton P; Marret S; Rouse D
    Cochrane Database Syst Rev; 2009 Jan; (1):CD004661. PubMed ID: 19160238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survey on use of antenatal magnesium sulphate for fetal neuroprotection prior to preterm birth in Australia and New Zealand - Ongoing barriers and enablers.
    Gatman K; May R; Crowther C
    Aust N Z J Obstet Gynaecol; 2020 Feb; 60(1):44-48. PubMed ID: 31119725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SOGC Clinical Practice Guideline. Magnesium sulphate for fetal neuroprotection.
    Magee L; Sawchuck D; Synnes A; von Dadelszen P; ;
    J Obstet Gynaecol Can; 2011 May; 33(5):516-529. PubMed ID: 21639972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of implementing magnesium sulphate for neuroprotection in a tertiary obstetric unit.
    Ow LL; Kennedy A; McCarthy EA; Walker SP
    Aust N Z J Obstet Gynaecol; 2012 Aug; 52(4):356-60. PubMed ID: 22515404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus.
    Doyle LW; Crowther CA; Middleton P; Marret S
    Cochrane Database Syst Rev; 2007 Jul; (3):CD004661. PubMed ID: 17636771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of antenatal magnesium sulphate on MRI biomarkers of white matter development at term equivalent age: The MagNUM Study.
    Poppe T; Thompson B; Boardman JP; Bastin ME; Alsweiler J; Deib G; Harding JE; Crowther CA;
    EBioMedicine; 2022 Apr; 78():103923. PubMed ID: 35331677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal obesity and neuroprotective magnesium sulfate.
    McPherson J; Smiley S; Stamilio D
    Am J Obstet Gynecol; 2015 Oct; 213(4):582.e1-6. PubMed ID: 26116874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers and enablers to implementing antenatal magnesium sulphate for fetal neuroprotection guidelines: a study using the theoretical domains framework.
    Bain E; Bubner T; Ashwood P; Van Ryswyk E; Simmonds L; Reid S; Middleton P; Crowther CA
    BMC Pregnancy Childbirth; 2015 Aug; 15():176. PubMed ID: 26283623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonreceipt of antenatal magnesium sulphate for fetal neuroprotection at the Women's and Children's Hospital, Adelaide 2010-2013.
    Siwicki K; Bain E; Bubner T; Ashwood P; Middleton P; Crowther CA
    Aust N Z J Obstet Gynaecol; 2015 Jun; 55(3):233-8. PubMed ID: 26084194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial.
    Crowther CA; Hiller JE; Doyle LW; Haslam RR;
    JAMA; 2003 Nov; 290(20):2669-76. PubMed ID: 14645308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preterm premature rupture of membranes at 22-25 weeks' gestation: perinatal and 2-year outcomes within a national population-based study (EPIPAGE-2).
    Lorthe E; Torchin H; Delorme P; Ancel PY; Marchand-Martin L; Foix-L'Hélias L; Benhammou V; Gire C; d'Ercole C; Winer N; Sentilhes L; Subtil D; Goffinet F; Kayem G
    Am J Obstet Gynecol; 2018 Sep; 219(3):298.e1-298.e14. PubMed ID: 29852153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. School-age outcomes of very preterm infants after antenatal treatment with magnesium sulfate vs placebo.
    Doyle LW; Anderson PJ; Haslam R; Lee KJ; Crowther C;
    JAMA; 2014 Sep; 312(11):1105-13. PubMed ID: 25226476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antenatal magnesium sulphate for the prevention of cerebral palsy in infants born preterm: a double-blind, randomised, placebo-controlled, multi-centre trial.
    Wolf HT; Brok J; Henriksen TB; Greisen G; Salvig JD; Pryds O; Hedegaard M; Weber T; Hegaard HK; Pinborg A; Huusom LD;
    BJOG; 2020 Sep; 127(10):1217-1225. PubMed ID: 32237024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrapartum magnesium sulfate is associated with neuroprotection in growth-restricted fetuses.
    Stockley EL; Ting JY; Kingdom JC; McDonald SD; Barrett JF; Synnes AR; Monterrosa L; Shah PS; ; ;
    Am J Obstet Gynecol; 2018 Dec; 219(6):606.e1-606.e8. PubMed ID: 30240651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.